Rare Disease Report

Glucocorticoids, Duchenne, and Pulmonary Function

OCTOBER 27, 2016
James Meyer



At the Child Neurology Society Annual Meeting (CNS 2016) in Vancouver, we talked with James Meyer, Senior Director of Medical Affairs at Marathon Pharmaceuticals about their poster presentation comparing deflazacort plus prednisone with placebo on pulmonary function in non-ambulatory boys with Duchenne muscular dystrophy.

Stay informed on the latest rare disease news and developments by signing up for our newsletter.
Copyright © RareDR 2013-2018 Rare Disease Communications. All Rights Reserved.